Comparison

DeviceAID vs Mitral Valve Strategy App

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

DeviceAID

Features
Read full description

DeviceAID is an educational application with many categories of devices used in both diagnostic Cath as well as interventional cardiology. With hundreds of devices to keep in your head, having a tool to get to the key few numbers can be invaluable. A basics section introduces devices, and the library section allows for the searching and filtering of devices based on some key characteristics. Current sections include Catheters, stents, balloons, atherectomy devices, access, closure, and more. Devices can be added to your personal favorites list for easy access later. For those who want to refine their knowledge of devices, quizzes with correct answer explanations are available.

About

Mitral Valve Strategy App

Features
Read full description

The M-TEER Strategy & Learning App is an intelligent, structured educational and procedural decision-support platform designed to help cardiologists understand, plan, execute, troubleshoot, and continuously improve transcatheter edge-to-edge mitral valve repair (M-TEER). The app bridges the gap between guidelines, imaging, anatomy, procedural strategy, device selection, real-time decision-making, and operator learning. Rather than functioning as a simple reference library, it is designed around the way a structural heart team actually approaches a patient: Understand the pathology → assess anatomy → determine feasibility → select the strategy → anticipate challenges → plan the procedure → execute systematically → assess the result → learn from the case. At its core is a comprehensive M-TEER Strategy Engine. The user enters clinical, echocardiographic, anatomical, and procedural variables, and the application generates a structured assessment of the case. It can classify the underlying mechanism of mitral regurgitation, identify important anatomical determinants of success, assess suitability for TEER, highlight potential limitations, and suggest alternative strategies when M-TEER may not be appropriate. The platform places imaging at the centre of decision-making. Users can systematically evaluate 2D TEE, 3D TEE, en-face views, X-plane imaging, commissural anatomy, leaflet length and mobility, coaptation characteristics, flail or prolapse morphology, calcification, clefts, commissural disease, mitral valve area, transmitral gradient, and the anticipated grasping zone. The objective is to translate complex echocardiographic information into a procedural mental model. A dedicated M-TEER Planning Module converts anatomy into strategy. It helps the operator determine the likely target zone, preferred imaging views, transseptal puncture considerations, device orientation, steering strategy, grasping sequence, and anticipated technical challenges. It can present the case as a structured procedural roadmap rather than isolated measurements. The app also incorporates Device Strategy and Knobology Learning. Different device platforms and generations can be studied through interactive procedural scenarios, allowing operators to understand steering, orientation, positioning, leaflet grasping, deployment, repositioning, and troubleshooting. The emphasis is not merely on knowing the device, but on understanding why a particular manoeuvre is being performed and what anatomical problem it is solving. A major component is the Complication & Troubleshooting Engine. Users can work through scenarios such as inadequate leaflet insertion, single-leaflet device attachment, suboptimal reduction of MR, high post-procedure transmitral gradient, device instability, difficult transseptal positioning, poor trajectory, challenging commissural anatomy, residual MR, or loss of grasp. The app encourages structured troubleshooting by asking: What is wrong? Why has it happened? What anatomical or procedural variable is responsible? What should be changed next? The platform is also designed as a Learning and Simulation Environment. Cases can be presented as progressive clinical simulations in which the learner makes decisions at each stage. The system can reveal consequences of those decisions, compare alternative strategies, and provide expert explanations. This creates an environment for deliberate practice before entering the catheterization laboratory. An integrated Case Library can contain normal mitral anatomy, degenerative MR, functional MR, mixed pathology, complex anatomy, failed procedures, bailout strategies, and challenging real-world cases. Each case can include clinical information, TTE, 2D/3D TEE, CT where relevant, procedural videos, questions, decision points, final strategy, outcome, and expert commentary.

Screenshots

DeviceAID4 screens
Mitral Valve Strategy App3 screens

Verdict

The call

The clearest difference is ads: Mitral Valve Strategy App at none against DeviceAID's shown. Mitral Valve Strategy App also leads on update cadence (daily vs every 14 months) and iOS requirement (13.0 vs 18.0). On price, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

DeviceAID ships an update every 14 months, Mitral Valve Strategy App daily. The most recent releases landed on October 23, 2026 and October 22, 2026 respectively.

Scorecard3 real differences · 5 level
DeviceAID versus Mitral Valve Strategy App: the parameters behind the verdict, then further details
ParameterDeviceAIDMitral Valve Strategy App
PriceFreeFree
Rating5.0 (1 ratings) — better—
Number of ratings1 — better—
Update frequencyEvery 14 monthsDaily — better
AdsYesNo — better
In-app purchasesNoNo
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS18.013.0 — better
Further details — not scored
Size60 MB24 MB
Age rating12+17+
DeveloperCardiology Apps LLCTECHOZE TECHNOLOGIES PRIVATE LIMITED

In-app purchases

None

DeviceAID

No in-app purchases

None

Mitral Valve Strategy App

No in-app purchases

Questions

Is DeviceAID free?
DeviceAID is free to download, with no in-app purchases.
Is Mitral Valve Strategy App free?
Mitral Valve Strategy App is free to download, with no in-app purchases.
Do DeviceAID or Mitral Valve Strategy App have ads?
DeviceAID shows ads; Mitral Valve Strategy App does not.
Which is updated more often, DeviceAID or Mitral Valve Strategy App?
DeviceAID ships an update every 14 months, and Mitral Valve Strategy App daily. Most recently, DeviceAID was updated on October 23, 2026 and Mitral Valve Strategy App on October 22, 2026.

Other comparisons